tadalafil has been researched along with Hypogonadism in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Fujihara, A; Harikai, S; Kanemitsu, N; Narukawa, T; Soh, J; Ukimura, O | 1 |
Huang, CC; Li, GY; Liang, JH; Liang, SK; Meng, ZB; Shen, SL; Song, WR; Wei, GQ; Zhang, X; Zhu, CH | 1 |
Cai, ZK; Dai, JC; Li, P; Li, Z; Wang, YX; Wang, Z; Zhang, W; Zheng, JH | 1 |
Carini, M; Chavalmane, A; Fibbi, B; Filippi, S; Forti, G; Maggi, M; Mancina, R; Marini, M; Morelli, A; Silvestrini, E; Vannelli, GB; Vignozzi, L | 1 |
Buvat, J; Colson, MH; Cuzin, B; Dean, JD; Eardley, I; Kaipia, A; Maggi, M; Martin-Morales, A; Meuleman, E; Moncada, I; Montorsi, F; Porst, H; Shabsigh, R; Yassin, A | 1 |
Li, J; Li, WX; Luo, L; Wang, S; Wang, XK | 1 |
Brock, G; Burnett, A; Ghanem, H; Giuliano, F; Glina, S; Hellstrom, W; Martin-Morales, A; Porst, H; Salonia, A; Sharlip, I | 1 |
1 review(s) available for tadalafil and Hypogonadism
Article | Year |
---|---|
SOP conservative (medical and mechanical) treatment of erectile dysfunction.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alprostadil; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Pyrimidines; Risk Factors; Sulfonamides; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Yohimbine | 2013 |
5 trial(s) available for tadalafil and Hypogonadism
Article | Year |
---|---|
Efficacy of testosterone replacement therapy plus alternate-day tadalafil for patients with late-onset hypogonadism: An open-label, randomized, crossover study.
Topics: Cross-Over Studies; Erectile Dysfunction; Humans; Hypogonadism; Male; Tadalafil; Testosterone | 2021 |
[Low-dose testosterone undecanoate capsules combined with tadalafil for late-onset hypogonadism accompanied with ED].
Topics: Adult; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypogonadism; Male; Middle Aged; Tadalafil; Testosterone; Treatment Outcome | 2013 |
[Safety and efficacy of L-carnitine and tadalafil for late-onset hypogonadism with ED: a randomized controlled multicenter clinical trial].
Topics: Adult; Aged; Carbolines; Carnitine; Erectile Dysfunction; Humans; Hypogonadism; Male; Middle Aged; Tadalafil; Treatment Outcome | 2014 |
Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study).
Topics: Administration, Topical; Aged; Aged, 80 and over; Analysis of Variance; Carbolines; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Hydrogels; Hypogonadism; Intention to Treat Analysis; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Tadalafil; Testosterone | 2011 |
[Tadalafil improves total testosterone, IIEF score and SEP in old and middle-aged males with late-onset hypogonadism].
Topics: Carbolines; Erectile Dysfunction; Humans; Hypogonadism; Male; Middle Aged; Sexual Behavior; Tadalafil; Testosterone; Treatment Outcome | 2012 |
1 other study(ies) available for tadalafil and Hypogonadism
Article | Year |
---|---|
Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism.
Topics: Animals; Carbolines; Disease Models, Animal; Erectile Dysfunction; Humans; Hypogonadism; In Vitro Techniques; Male; Penis; Phosphodiesterase Inhibitors; Prostatectomy; Rats; Rats, Sprague-Dawley; Tadalafil | 2009 |